Subject Injury Sample Clauses

Subject Injury. A. V případě, že subjektu nastane újma přímým následkem jeho účasti v Klinickém hodnocení, jak bude společně stanoveno Zkoušejícím a Zadavatelem, bude Zdravotnické zařízení žádat o odpovídající úhradu všech souvisejících nákladů zdravotní péče pojišťovnu subjektu, plán řízené péče nebo jiný program výhod. Pokud budou náklady související s takovou újmou převyšovat rámec výdajů hrazených pojišťovnou subjektu, plánem řízené péče nebo jiným programem výhod, jak ověří Zdravotnické zařízení předtím, než bude předložen účet jakémukoli takovému plátci třetí strany, bude Zdravotnické zařízení žádat uhrazení těchto nákladů Zadavatele, Zadavatel však neposkytne žádné platby za náklady, které lze přisoudit: A. In the event that a subject is injured as a direct result of his or her participation in the Study, as determined jointly by Investigator and Sponsor, then Institution shall seek appropriate reimbursement for all related costs of care from the subject’s insurer, managed care plan, or other benefits program. If costs related to such an injury are outside the scope of covered benefits for a subject’s insurer, managed care plan, or other benefit program, as determined by Institution prior to a bill being submitted to any such third party payor, then Institution shall seek reimbursement from Sponsor for such costs; provided, however, that Sponsor shall not provide any payment for costs that are attributable to: i. nedodržení podmínek Protokolu nebo jakýchkoli písemných pokynů Zadavatele souvisejících s užíváním Hodnoceného přípravku nebo nesplnění příslušných požadavků FDA nebo jiných státních úřadů i. the failure of the Site, or any Site personnel involved in the performance of the Study, to adhere to the terms of the Protocol or any of Sponsor’s written instructions relative to the use of the Study Medication, or to Řešitelským centrem nebo kýmkoli ze zaměstnanců Řešitelského centra podílejícího se na provádění Klinického hodnocení, s výjimkou toho, kdy je takové pochybení v souladu s všeobecně přijímanými standardy klinického výzkumu a lékařské praxe ve vztahu k přínosům, bezpečnosti a blahu Subjektů klinického hodnocení nebo jak bude jinak důvodně potřebné pro bezpečnost takového subjektu, vždy na základě rozhodnutí Zkoušejícího učiněného v dobré víře; ii. jakékoli nedbalosti nebo protiprávnímu jednání nebo opomenutí nebo úmyslnému trestnému činu Řešitelského centra nebo jakéhokoli jiného zaměstnance Řešitelského centra poskytujícího služby jménem Řešitelského c...

Subject Injury. (a) Company agrees to reimburse Institution for (or otherwise pay for) the costs of the care and treatment of any side effect, adverse reaction, illness, or injury to a subject resulting from a defect in the Study Drug. (b) Company’s subject injury commitment under (a) above shall not apply to any side effect, adverse reaction, illness, or injury to the extent it directly results from: (i) the negligence or reckless or intentional misconduct of, or violation of law by, Institution, Principal Investigator, or Institution’s personnel; or (ii) failure of Institution, Principal Investigator, or Institution’s personnel to adhere to the terms of the Protocol for the Study, provided, however, that emergency medical care shall not be deemed a violation of the Protocol.

Subject Injury. If a Study subject suffers an adverse reaction, medical illness, or injury which was directly caused by a {CHOOSE: Study Drug or Study Device} and/or any properly performed procedures required by the Protocol, Sponsor shall reimburse for the reasonable and necessary expenses of diagnosis and treatment of any Study subject injury, including hospitalization, but only to the extent such adverse reaction, medical illness or injury are not directly caused by (i) Institution's negligence or willful misconduct; (ii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study; or (iii) Institution’s failure to adhere to and comply with the specifications of the Protocol and all reasonable written instructions furnished by Sponsor for the use and administration of any {CHOOSE: Study Drug or Study Device} used in the Study, provided that deviations from the Protocol and written instructions resulting from an imminent threat to the health or safety of a Study subject that do not cause the injury to the Study subject will not disqualify Institution from reimbursement under this provision.

Subject Injury. The Sponsor shall reimburse the Institution for the reasonable and necessary medical expenses incurred in treating any injury or illness to a Study Subject that are directly related to the administration of the Investigational Drug or the proper performance of any other Study procedure, each in accordance with the Protocol and the Sponsor’s written instructions to the Institution/Principal Investigator. The Sponsor is not required to provide compensation for (a) other injury- or illness-related costs (such as lost wages), (b) medical expenses that are paid for by a third party, (c) medical expenses that are incurred as the result of a violation of the Protocol or other misconduct or negligence, in each case by any agent or employee of the Institution (including the Study Staff), or (d) medical expenses for injury or illness unrelated to the Investigational Drug and unrelated to the proper performance of any other procedure required by the Protocol or Sponsor’s written instructions to the Institution/Principal Investigator, including, without limitation, medical expenses associated with a pre-existing medical condition or the progression of the underlying disease.

Subject Injury. Sponsor shall reimburse the cost of providing necessary medical treatment to a Study subject for any injuries directly resulting from a Study subject’s participation in the Study, unless Institution’s negligence or willful misconduct caused the injury.

Subject Injury. As between the Parties, [***] shall not be liable to any Clinical Study subject for any injury, illness or side effect experienced or alleged to be experienced by such subject due to the subject’s participation in the Clinical Study, including any injury, illness or side effect caused by (a) any negligence or misconduct of [***], (b) [***], or (c) [***].

Subject Injury. Sponsor shall reimburse the Institution for the reasonable and necessary medical expenses for the treatment of any illness or injury to a Study Subject as a direct result of the proper administration of the Study Drug or performance of any procedures in strict accordance with the Protocol. Sponsor shall not reimburse for any illness or injury to the extent such illness or injury is attributable to the: (i) Institution Indemnitees’ negligent activities, reckless misconduct, intentional misconduct or omissions; (ii) failure of Institution Indemnitees to comply with all Applicable Laws; (iii) failure of Institution Indemnitees to adhere to the terms of the Protocol or this Agreement, or (iv) the natural progression of Study Subject’s disease or underlying condition.

Subject Injury. Institution shall provide medical treatment to Study Subjects who suffer an adverse reaction or injury during the Study. Rigel shall reimburse Institution for the actual and reasonable costs of providing such medical treatment, to the extent the adverse reaction or injury was directly caused by the correct administration of the Study Drug or by the Protocol procedures. ▇▇▇▇▇’▇ obligation to reimburse Institution shall not apply where such adverse reaction or injury is caused by the negligence or misconduct of Institution, Investigator or other Study Personnel, or where such adverse reaction or injury is caused by a pre-existing medical condition or underlying disease of the Study Subject.

Subject Injury. [Note to Drafter: Please review funding to determine any additional or lesser benefits or obligations flow to CHCO.]